Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection

Journal of Clinical Microbiology

Volumn 50, Issue 3, 2012, Pages 1102-1105

  Maduka Ezeh, Awele ^a   Seville, Maria Teresa ^b   Kusne, Shimon ^b   Vikram, Holenarasipur R ^b   Blair, Janis E ^b   Greenwood Quaintance, Kerryl ^a   Arabia, Francisco ^b   Patel, Robin ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFOXITIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; LEVOFLOXACIN; LINEZOLID; MINOCYCLINE; OXACILLIN; RIFAMPICIN; THYMIDINE; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; AUXOTROPHY; CASE REPORT; DEFIBRILLATOR; DEVICE INFECTION; FEMALE; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; PACEMAKER; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; STAPHYLOCOCCUS AUREUS; THYMIDINE AUXOTROPHIC STAPHYLOCOCCUS AUREUS; TRICUSPID VALVE;

ADULT; ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVES; HUMANS; MICROBIAL SENSITIVITY TESTS; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; THYMIDINE;

EID: 84857389502     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01170-11     Document Type: Article

References (28)

1. Alatoom AA, Cunningham SA, Ihde SM, Mandrekar J, Patel R. 2011. Comparison of direct colony method versus extraction method for identification of Gram-positive cocci by use of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 49:2868-2873.
2. Balwit JM, van Langevelde P, Vann JM, Proctor RA. 1994. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J. Infect. Dis. 170:1033-1037. (Pubitemid 24296593)
3. Bates DM, et al. 2003. Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney. J. Infect. Dis. 187:1654-1661. (Pubitemid 36578972)
4. Baumert N, et al. 2002. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb. Drug Resist. 8:253-260. (Pubitemid 36043690)
5. Besier S, Ludwig A, Ohlsen K, Brade V, Wichelhaus TA. 2007. Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int. J. Med. Microbiol. 297:217-225. (Pubitemid 46830044)
6. Besier S, et al. 2008. The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 52:2183-2189. (Pubitemid 351758557)
7. Besier S, et al. 2008. Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease. J. Clin. Microbiol. 46:3829-3832.
8. Cabell CH, et al. 2004. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am. Heart J. 147:582-586. (Pubitemid 38900441)
9. Chatterjee I, et al. 2008. In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus. J. Bacteriol. 190:834-842. (Pubitemid 351170926)
10. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. CLSI document M07-A8, vol 29, no 2, p 21-22. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Clincal and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI document M100-S21, vol 30, no 1. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Deighton M, Borland R. 1993. Regulation of slime production in Staphylococcus epidermidis by iron limitation. Infect. Immun. 61:4473-4479. (Pubitemid 23298612)
13. Ferguson RW, Weissfeld AS. 1984. Comparison of the suitability of three common bacterial media for susceptibility testing of trimethoprim- sulfamethoxazole. J. Clin. Microbiol. 19:85-86. (Pubitemid 14213313)
14. Frank KL, Reichert EJ, Piper KE, Patel R. 2007. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob. Agents Chemother. 51:888-895. (Pubitemid 46355272)
15. Gilligan PH, Gage PA, Welch DF, Muszynski MJ, Wait KR. 1987. Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J. Clin. Microbiol. 25:1258-1261. (Pubitemid 17084222)
16. Herrmann M, et al. 1997. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 95:814-817. (Pubitemid 27091519)
17. Kahl B, et al. 1998. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 177:1023-1029. (Pubitemid 28155157)
18. Kohner P, Uhl J, Kolbert C, Persing D, and Cockerill F, III. 1999. Comparison of susceptibility testing methods with mecA gene analysis for determining oxacillin (methicillin) resistance in clinical isolates of Staphylococcus aureus and coagulase-negative Staphylococcus spp. J. Clin. Microbiol. 37:2952-2961. (Pubitemid 29391916)
19. Kristich CJ, Li YH, Cvitkovitch DG, Dunny GM. 2004. Esp-independent biofilm formation by Enterococcus faecalis. J. Bacteriol. 186:154-163. (Pubitemid 38020297)
20. Massey RC, Buckling A, Peacock SJ. 2001. Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr. Biol. 11:1810-1814. (Pubitemid 33092172)
21. McNamara PJ, Proctor RA. 2000. Staphylococcus aureus small colony variants, electron transport and persistent infections. Int. J. Antimicrob. Agents 14:117-122. (Pubitemid 30138178)
22. Nery PB, et al. 2010. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J. Cardiovasc. Electrophysiol. 21:786-790.
23. Sakai H, et al. 2004. Simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci in positive blood cultures by real-time PCR with two fluorescence resonance energy transfer probe sets. J. Clin. Microbiol. 42:5739-5744. (Pubitemid 39664361)
24. Singh R, Ray P, Das A, Sharma M. 2010. Enhanced production of exopolysaccharide matrix and biofilm by a menadione-auxotrophic Staphylococcus aureus small-colony variant. J. Med. Microbiol. 59:521-527.
25. Singh R, Ray P, Das A, Sharma M. 2009. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J. Med. Microbiol. 58:1067-1073.
26. Tuchscherr L, et al. 2010. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J. Infect. Dis. 202:1031-1040.
27. von Eiff C, et al. 2006. Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J. Bacteriol. 188:687-693.
28. Zander J, et al. 2008. Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus. Infect. Immun. 76:1333-1339. (Pubitemid 351561978)